Modulation of Dopaminergic VTA Neurons by Urotensin II
Modulation of Dopaminergic VTA Neurons by Urotensin II
批准号:
7589229
负责人:
Stewart Donaldson Clark
金额:
$11.06万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-01 至 2011-05-31
关键词:
AblationAnatomyAnimalsBehaviorBehavioralBehavioral ParadigmBindingBrainBrain StemCaliforniaCell NucleusCollaborationsCommunicationComplexConsumptionDataDevelopmentDiffuseDiphtheriaDiphtheria ToxinDiseaseDopamineEffectivenessElectron MicroscopyEnvironmentEventFacultyFosteringFusion ToxinFutureHome environmentIbotenic AcidImmunohistochemistryIn SituInvestigationLeftLesionManuscriptsMapsMediatingMentorsMethodsMicrodialysisMolecularMotivationNeurobiologyNeuronal PlasticityNeuronsNeuropeptidesNeuropharmacologyNeurotransmittersNicotineNucleus AccumbensOutputPathway interactionsPharmaceutical PreparationsPilot ProjectsPositioning AttributePostdoctoral FellowPrincipal InvestigatorPsychotropic DrugsRegulationResearchResourcesRewardsRoleScientistSelf AdministrationServicesStimulusStructureSucroseSynapsesSystemTechniquesTegmentum MesencephaliTissuesToxinTracerUniversitiesVentral Tegmental AreaWorkWritingaddictionbasecareercholinergicdopaminergic neurondrug of abusegoal oriented behaviorlaterodorsal tegmentummotivational processesneurochemistryneurotransmitter releasenovelpedunculopontine tegmentumpreferenceprepulse inhibitionpublic health relevancereceptorreinforced behaviorresponsereward processingtransmission processurotensin II
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The mesolimbic pathway through the release of dopamine from neurons in the ventral tegmental area (VTA), which project to the nucleus accumbens (NAc), is thought to have a role in motivation and reward processes. Some addictive drugs produce their potent effects on behavior by enhancing mesolimbic dopamine activity. Release of dopamine from VTA neurons is controlled by various factors and neuronal structures. One pathway providing regulatory input to the VTA originates in the mesopontine nuclei of the brainstem. The candidate has shown that the mesopontine-VTA-NAc pathway is modulated by the novel neuropeptide urotensin II (UII).
The candidate has also shown utility of a fusion of diphtheria toxin with Ull. This toxin is able to selectively ablate UII-R expressing neurons without damage to surrounding tissue. Through the combination of this toxin with microdialysis and behavioral paradigms, we will establish whether Ull can modulate reinforced behaviors. In other work Ull has been shown to produce cellular remolding, which may point to a role in neuroplasticity. Therefore, future studies will include the investigation of the role of UII-R in molecular neurobiological changes and the development of addiction.
The University of California, Irvine is home to a unique concentration of established scientists in the field of novel neuropeptide function. This collaborative environment will expose the candidate to many different aspects of the characterization of novel neuropeptide systems. Throughout his graduate career, and subsequent post-doctoral research, the candidate has been responsible for the primary research, initiating and fostering of collaborations, and the writing of manuscripts. Therefore, the transition to establishing independent research in to the molecular neuropharmacology of the Ull system should be smooth. The mentors' roles will be to provide space and resources for the completion of research of sufficient quality to allow the candidate to successfully compete for a faculty position at an outstanding research university.
PUBLIC HEALTH RELEVANCE: The current proposal is relevant in that the novel neuropeptide urotensin II may be a previously unrecognized player in the regulation of motivational processes. The investigation of which may add another layer of understanding the complex action of psychoactive drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tau accumulation in the pedunculopontine tegmentum as an early node in Progressive Supranuclear Palsy pathogenesis
-
批准号:10209162
-
项目类别:
-
资助金额:$180.84万
-
财政年份:2021
-
负责人:Stewart Donaldson Clark
-
依托单位:
Tau accumulation in the pedunculopontine tegmentum as an early node in Progressive Supranuclear Palsy pathogenesis
-
批准号:10204268
-
项目类别:
-
资助金额:$55.21万
-
财政年份:2020
-
负责人:Stewart Donaldson Clark
-
依托单位:
Discovering Small Molecule Biased Agonists for the Neuropeptide S Receptor
-
批准号:9917358
-
项目类别:
-
资助金额:$73.27万
-
财政年份:2019
-
负责人:Stewart Donaldson Clark
-
依托单位:
Discovering Small Molecule Biased Agonists for the Neuropeptide S Receptor
-
批准号:10295776
-
项目类别:
-
资助金额:$73.03万
-
财政年份:2019
-
负责人:Stewart Donaldson Clark
-
依托单位:
Modulation of Dopaminergic VTA Neurons by Urotensin II
-
批准号:8269330
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Stewart Donaldson Clark
-
依托单位:
Modulation of Dopaminergic VTA Neurons by Urotensin II
-
批准号:8675360
-
项目类别:
-
资助金额:$3.84万
-
财政年份:2011
-
负责人:Stewart Donaldson Clark
-
依托单位:
Modulation of Dopaminergic VTA Neurons by Urotensin II
-
批准号:8309026
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Stewart Donaldson Clark
-
依托单位:
Modulation of Dopaminergic VTA Neurons by Urotensin II
-
批准号:8515980
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2011
-
负责人:Stewart Donaldson Clark
-
依托单位:
海外基金